Alx Oncology Holdings (ALXO) Prepaid Assets (2019 - 2026)
Alx Oncology Holdings recorded quarterly Prepaid Assets of $295000.0 in Q1 2026, down 95.03% quarter-over-quarter from $5.9 million in Q4 2025, and down 93.72% year-over-year from $4.7 million in Q1 2025.
Alx Oncology Holdings' Prepaid Assets history runs 8 years deep, the most recent figure standing at $295000.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 93.72% year-over-year to $295000.0; the TTM figure through Mar 2026 stood at $295000.0 (down 93.72% YoY), while the FY2025 annual figure was $5.9 million, down 9.98% from the prior year.
- Prepaid Assets came in at $295000.0 for Q1 2026 at Alx Oncology Holdings, down from $5.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.4 million in Q1 2024 to a low of $295000.0 in Q1 2026.
- A 5-year average of $4.9 million and a median of $4.9 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets sank 95.32% in 2024 and soared 1786.67% in 2025, its largest moves.
- Alx Oncology Holdings' Prepaid Assets stood at $4.8 million in 2022, then plunged by 82.57% to $830000.0 in 2023, then surged by 694.58% to $6.6 million in 2024, then dropped by 9.98% to $5.9 million in 2025, then slumped by 95.03% to $295000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $295000.0, $5.9 million, and $892000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 295,000.00 |
| Dec 31, 2025 | 5.94 Mn |
| Sep 30, 2025 | 892,000.00 |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 6.60 Mn |
| Sep 30, 2024 | 7.32 Mn |
| Jun 30, 2024 | 315,000.00 |
| Mar 31, 2024 | 10.43 Mn |
| Dec 31, 2023 | 830,000.00 |
| Sep 30, 2023 | 9.06 Mn |
| Jun 30, 2023 | 6.73 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | 5.90 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 4.93 Mn |
| Dec 31, 2021 | 3.35 Mn |
| Sep 30, 2021 | 3.81 Mn |
| Jun 30, 2021 | 2.31 Mn |
| Mar 31, 2021 | 2.47 Mn |
| Dec 31, 2020 | 1.77 Mn |
| Sep 30, 2020 | 2.39 Mn |
| Jun 30, 2020 | 1.39 Mn |
| Dec 31, 2019 | 256,000.00 |